NKGen Biotech
Why Robinhood?
You can watch NKGen Biotech and buy or sell other stocks, ETFs, and their options commission-free!About NKGN
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression.
NKGN Key Statistics
Stock Snapshot
With a market cap of 7.84M, NKGen Biotech(NKGN) trades at $0.06. The stock has a price-to-earnings ratio of -0.05.
On 2026-05-23, NKGen Biotech(NKGN) stock traded between a low of $0.06 and a high of $0.06. Shares are currently priced at $0.06, which is 0.0% above the low and 0.0% below the high.
The NKGen Biotech(NKGN)'s current trading volume is 177, compared to an average daily volume of 6.35K.
During the past year, NKGen Biotech(NKGN) stock moved between $0.00 at its lowest and $0.46 at its peak.
During the past year, NKGen Biotech(NKGN) stock moved between $0.00 at its lowest and $0.46 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.